Well, they filed an 8-K for the Cytovia sale.
freeedgar.com
The most important paragraph:
<<Following completion of the repurchase of the 3,180 shares of Series E Preferred, and taking into account conversions of the Series E Preferred through May 17, 1999, $1,797,000 (including accrued dividends) of Series E Preferred remains outstanding. As of that date, CoCensys had 4,633,000 shares of common stock issued and outstanding. >>
Just have to sit around for a bit and wait for the announcement of the epilepsy partnership.
Anaxagoras |
